In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Drug:  isotretinoin
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2009-01064, CDR0000069018, COG-ANBL0032, ANBL0032, U10CA098543, COG-P9842, NCT00026312

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 20 at diagnosis
Sponsor: Other
Protocol IDs: CDR0000069191, SIOP-EUROPE-HR-NBL-1, ESIOP, EU-20148, NCT00030719

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 90 days to 18 years
Sponsor: Other
Protocol IDs: LINES, NCT01728155

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: 012010, 2009-018077-31, NCT01701479

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-159, NCT01183429

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-160, NCT01183884

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-161, NCT01183897

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 19
Sponsor: Other
Protocol IDs: NB2012, NCT01857934

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-02011, N2011-04, CDR0000741991, NANT N2011-04, NANT 2011-04, P01CA081403, NCT01711554

10.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 months to 3 years
Sponsor: NCI
Protocol IDs: NCI-2012-03167, PBTC-026, U01CA081457, NCT00867178

11.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: ANBL09P1, NCI-2011-01745, CDR0000682629, U10CA098543, COG-ANBL09P1, NCT01175356

12.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: 2011OC072, MT2011-11C, NCT01526603

13.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 13-260, NCT02100930
New Search